Form SCHEDULE 13D/A ZOOZ Strategy Ltd. Filed by: Zheng Fang

Item 2(b) is hereby amended and restated as follows: The principal business and principal office address of Mr. Zheng is as follows: Room 3008-10, 30/F, Cosco Tower 183 Queen's Road Central, Hong Kong The principal business and principal office address of the Sponsor is as follows: 275 Madison Avenue, 39th Floor New York, New York 10016 The principal business and principal office address of Keywise is as follows: Room 3008-10, 30/F, Cosco Tower 183 Queen's Road Central, Hong Kong

Item 2(c) is hereby amended and restated as follows: Mr. Zheng is the majority shareholder of the Sponsor and the director and the sole investor of Keywise.

Each of the Reporting Persons has not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

Each of the Reporting Persons has not, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which such Reporting Person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Item 2(f) is hereby amended and restated as follows: Mr. Zheng is a citizen and resident of Hong Kong. The Sponsor is a Cayman Islands exempted company. Keywise is a Cayman Islands fund.

Item 3 is hereby amended and supplemented with the following: On September 26, 2025, Keywise acquired an aggregate of 8,000,000 Ordinary Shares upon the closing of a private placement transaction pursuant to that certain Securities Purchase Agreement dated July 29, 2025 (the "Private Placement"). Mr. Fang Zheng has sole voting and dispositive power over the shares held by Keywise.

Item 4 is hereby amended and supplemented as follows: The information set forth in Item 3 is hereby incorporated by reference in its entirety. The Reporting Persons acquired the 8,000,000 Ordinary Shares in connection with the Private Placement for investment purposes. The Reporting Persons have no plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) and (c) through (j) of Item 4 of Schedule 13D. The Reporting Persons reserve the right to formulate plans and/or proposals and to take such actions with respect to his investments in the Issuer, including any or all of the actions set forth in clauses (a) through (j) of Item 4 of Schedule 13D.

Item 5(a) is hereby amended and restated as follows: Mr. Zheng is deemed to beneficially own an aggregate of 10,614,800 Ordinary Shares, comprised of (i) 150,000 Ordinary Shares held by Mr. Zheng, (ii) 2,219,550 Ordinary Shares held by the Sponsor, (iii) 8,000,000 Ordinary Shares held by Keywise and (iv) 245,250 Ordinary Shares issuable upon the exercise of the Warrants held by the Sponsor. The Warrants are exercisable until May 4, 2029, and each Warrant is exercisable for one Ordinary Share at an exercise price of $11.50 per share. Mr. Zheng is the majority shareholder of the Sponsor and has sole voting and dispositive power over the shares held by Keywise, and as such, he may be deemed to be the beneficial owner of all of the securities of the Issuer held of record by the Sponsor and Keywise. Mr. Zheng disclaims any beneficial ownership of the reported securities held by the Sponsor and Keywise other than to the extent of any pecuniary interest he may have therein, directly or indirectly. The Sponsor is deemed to beneficially own an aggregate of (i) 2,219,550 Ordinary Shares and (ii) 245,250 Ordinary Shares issuable upon the exercise of private Warrants. The Warrants are exercisable until May 4, 2029, and each Warrant is exercisable for one Ordinary Share at an exercise price of $11.50 per share. Keywise is deemed to beneficially own 8,000,000 Ordinary Shares. The foregoing represents beneficial ownership of approximately 6.5% by Mr. Zheng, 1.5% by the Sponsor and 4.9% by Keywise of the outstanding Ordinary Shares based on 162,022,482 outstanding Ordinary Shares as of April 10, 2026.

Mr. Zheng has the sole power to dispose or direct the disposition of all of the Ordinary Shares that the Reporting Persons beneficially owned as of April 10, 2026.

Except as described in Item 3, the Reporting Persons have not effected any transactions in the Ordinary Shares of the Issuer in the past 60 days.

Not applicable.

Not applicable.

Item 6 is hereby amended and supplemented with the following: The information contained in Items 2, 3, 4 and 5 of this Schedule 13D is incorporated by reference herein. On July 29, 2025, the Issuer and Keywise entered into a Securities Purchase Agreement (the "Securities Purchase Agreement") in connection with the Private Placement for the purchase of 8,000,000 Ordinary Shares for an aggregate purchase price of approximately $8,000,000 from the Private Placement. The closing of the Private Placement occurred on September 26, 2025, at which time the 8,000,000 Ordinary Shares were issued to Keywise. The Ordinary Shares acquired in connection with the Private Placement are subject to registration rights, as set forth in a registration rights agreement dated July 29, 2025.

Exhibit No. Description 1 Joint Filing Agreement. 2 Business Combination Agreement (as amended) dated July 30, 2023, among the Issuer, Keyarch, Merger Sub, the Sponsor and the Company Representative (incorporated herein by reference to Exhibits 2.1 through 2.4 to the Issuer's Amendment No. 2 to Form F-4/A filed on March 15, 2023). 3 Form of Subscription Agreement, by and among the Issuer, Keyarch, and the subscribers party thereto (incorporated herein by reference to Exhibit 10.20 to the Issuer's Amendment No. 2 to Form F-4/A filed on March 15, 2023). 4 Letter Agreement, dated as of January 22, 2022, by and among the Issuer, the Sponsor, the other parties thereto and EarlyBirdCapital, Inc. (incorporated by reference to Exhibit 10.1 to Keyarch's Current Report on Form 8-K filed with the SEC on January 27, 2022). 5 Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.2 to the Issuer's Report on Form 6-K filed with the SEC on August 8, 2025). 6 Form of Registration Rights Agreement (incorporated by reference to Exhibit 10.5 to the Issuer's Report on Form 6-K filed with the SEC on August 8, 2025).